Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Abstract 5827: Identification of potential novel drivers and biomarkers of CDK4/6 inhibitor resistance in metastatic breast cancer

Leonie F. Ott, Malik Alawi, Malgorzata Stoupiec, Elena Laakmann, Malte Kriegs, Volkmar Müller, Klaus Pantel, Sabine Riethdorf

Cancer Res (2024) 84 (6_Supplement): 5827.

https://doi.org/10.1158/1538-7445.AM2024-5827

Published: 22 March 2024

View article titled, Abstract 5827: Identification of potential novel drivers and biomarkers of CDK4/6 inhibitor resistance in metastatic breast cancer

Journal Articles

Abstract 3370: Liquid biopsy approaches to determine tumor cell heterogeneity in advanced prostate cancer

Lina Merkens, Sarah Greimeier, Sabine Riethdorf, Klaus Pantel, Gunhild von Amsberg, Stefan Werner

Cancer Res (2023) 83 (7_Supplement): 3370.

https://doi.org/10.1158/1538-7445.AM2023-3370

Published: 04 April 2023

View article titled, Abstract 3370: Liquid biopsy approaches to determine tumor cell heterogeneity in advanced prostate cancer

Journal Articles

Abstract PD18-07: Omission of chemotherapy in the treatment of HER2-positive and hormone-receptor positive metastatic breast cancer – interim results from the randomized phase 3 DETECT V trial

Cancer Res (2023) 83 (5_Supplement): PD18-07.

https://doi.org/10.1158/1538-7445.SABCS22-PD18-07

Published: 01 March 2023

View article titled, Abstract PD18-07: Omission of chemotherapy in the treatment of HER2-positive and hormone-receptor positive metastatic breast cancer – interim results from the randomized phase 3 DETECT V trial

Journal Articles

Abstract 3374: Large-scale single-cell whole transcriptomic analyses reveal distinct malignant phenotypes of CTCs from NSCLC patients

Cancer Res (2022) 82 (12_Supplement): 3374.

https://doi.org/10.1158/1538-7445.AM2022-3374

Published: 15 June 2022

View article titled, Abstract 3374: Large-scale single-cell whole transcriptomic analyses reveal distinct malignant phenotypes of CTCs from NSCLC patients

Journal Articles

Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data

Cancer Res (2021) 81 (4_Supplement): GS4-08.

https://doi.org/10.1158/1538-7445.SABCS20-GS4-08

Published: 15 February 2021

View article titled, Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data

Journal Articles

Abstract PD3-12: Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial

Tanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, Peter A Fasching, Thomas WP Friedl, Andreas Hartkopf, Jens Huober, Christian Loehberg, Brigitte Rack, Sabine Riethdorf, Andreas Schneeweiss, Diethelm Wallwiener, Franziska Meier-Stiegen, Oliver Hoffmann, Lothar Müller, Pauline Wimberger, Eugen Ruckhaeberle, Jens Blohmer, Wolfgang Janni

Cancer Res (2021) 81 (4_Supplement): PD3-12.

https://doi.org/10.1158/1538-7445.SABCS20-PD3-12

Published: 15 February 2021

View article titled, Abstract PD3-12: Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial

Journal Articles

Abstract OT3-18-01: Detect III/IV study trial - The multicenter study program in patients with HER2-negative MBC and circulating tumor cells

Sabrina Krause, Thomas WP Friedl, Peter A Fasching, Andreas Schneeweiss, Volkmar Müller, Sabine Riethdorf, Klaus Pantel, Florin-Andrei Taran, Arkadius Polasik, Marie Tzschaschel, Amelie de Gregorio, Franziska Meier-Stiegen, Jens Huober, Wolfgang Janni, Tanja Fehm

Cancer Res (2020) 80 (4_Supplement): OT3-18-01.

https://doi.org/10.1158/1538-7445.SABCS19-OT3-18-01

Published: 15 February 2020

View article titled, Abstract OT3-18-01: Detect III/IV study trial - The multicenter study program in patients with HER2-negative MBC and circulating tumor cells

Journal Articles

Abstract OT2-01-03: DETECT V - Comparison of dual HER2-targeted therapy with trastuzumab and pertuzumab plus CDK4/6 inhibition in combination with either chemo- or endocrine therapy in patients with HER2-positive and hormone-receptor positive metastatic breast cancer

Thomas WP Friedl, Sabrina Krause, Tanja Fehm, Peter A Fasching, Andreas Schneeweiss, Volkmar Müller, Sabine Riethdorf, Klaus Pantel, Florin-Andrei Taran, Arkadius Polasik, Marie Tzschaschel, Amelie de Gregorio, Franziska Meier-Stiegen, Wolfgang Janni, Jens Huober

Cancer Res (2020) 80 (4_Supplement): OT2-01-03.

https://doi.org/10.1158/1538-7445.SABCS19-OT2-01-03

Published: 15 February 2020

View article titled, Abstract OT2-01-03: DETECT V - Comparison of dual HER2-targeted therapy with trastuzumab and pertuzumab plus CDK4/6 inhibition in combination with either chemo- or endocrine therapy in patients with HER2-positive and hormone-receptor positive metastatic breast cancer

Journal Articles

Abstract 2219: Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma of the bladder

Sonja Bergmann, Anja Coym, Gunhild von Amsberg, Melanie Janning, Armin Soave, Michael Rink, Klaus Pantel, Sabine Riethdorf

Cancer Res (2019) 79 (13_Supplement): 2219.

https://doi.org/10.1158/1538-7445.AM2019-2219

Published: 01 July 2019

View article titled, Abstract 2219: Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma of the bladder

Journal Articles

Abstract CT066: Dendritic cell based cryoimmunotherapy associates with clinical variables and changes in T-cell receptor expression in a prospective phase I trial of metastatic castration resistant prostate cancer

Cancer Res (2018) 78 (13_Supplement): CT066.

https://doi.org/10.1158/1538-7445.AM2018-CT066

Published: 01 July 2018

View article titled, Abstract CT066: Dendritic cell based cryoimmunotherapy associates with clinical variables and changes in T-cell receptor expression in a prospective phase I trial of metastatic castration resistant prostate cancer

Journal Articles

Abstract 5581: Clinical validation of a highly sensitive assay to detect mutations in plasma from advanced lung adenocarcinoma patients

Harriet Wikman, Malte Mohme, Melanie Janning, Alexander Sartori, Katrin Lamszus, Sabine Riethdorf, Darryl Irwin, Manfred Westphal, Sonja Loges, Klaus Pantel

Cancer Res (2018) 78 (13_Supplement): 5581.

https://doi.org/10.1158/1538-7445.AM2018-5581

Published: 01 July 2018

View article titled, Abstract 5581: Clinical validation of a highly sensitive assay to detect mutations in plasma from advanced lung adenocarcinoma patients

Journal Articles

Abstract 5693: Low coverage genome-wide sequencing of cell-free DNA enables detection, therapeutic monitoring, and characterization of copy number alterations in patients with solid tumors

Christopher K. Ellison, Aaron M. Goodman, Sabine Riethdorf, Amin R. Mazloom, Lisa Tran, Prachi Nakashe, Erin McCarthy, Tobias Gorges, Alexander Stein, Julia Quidde, Daniel S. Grosu, Mathias Ehrich, Taylor J. Jensen, Klaus Pantel, Razelle Kurzrock

Cancer Res (2017) 77 (13_Supplement): 5693.

https://doi.org/10.1158/1538-7445.AM2017-5693

Published: 01 July 2017

View article titled, Abstract 5693: Low coverage genome-wide sequencing of cell-free DNA enables detection, therapeutic monitoring, and characterization of copy number alterations in patients with solid tumors

Journal Articles

Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response

Kai Bartkowiak, Marcel Kwiatkowski, Friedrich Buck, Tobias M. Gorges, Lars Nilse, Volker Assmann, Antje Andreas, Volkmar Müller, Harriet Wikman, Sabine Riethdorf, Hartmut Schlüter, Klaus Pantel

Cancer Res (2015) 75 (24): 5367–5377.

https://doi.org/10.1158/0008-5472.CAN-14-3728

Published: 14 December 2015

View article titled, Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response

Includes: Supplementary data

Journal Articles

Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing

Ellen Heitzer, Martina Auer, Christin Gasch, Martin Pichler, Peter Ulz, Eva Maria Hoffmann, Sigurd Lax, Julie Waldispuehl-Geigl, Oliver Mauermann, Carolin Lackner, Gerald Höfler, Florian Eisner, Heinz Sill, Hellmut Samonigg, Klaus Pantel, Sabine Riethdorf, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher

Cancer Res (2013) 73 (10): 2965–2975.

https://doi.org/10.1158/0008-5472.CAN-12-4140

Published: 12 May 2013

View article titled, Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing

Includes: Supplementary data

Journal Articles

Abstract 4547: Clinical relevance of circulating tumor cells in esophageal cancer

Katharina E. Effenberger, Matthias Reeh, Sabine Riethdorf, Dominique Eichstaedt, Jakob R. Izbicki, Maximilian Bockhorn, Klaus Pantel

Cancer Res (2012) 72 (8_Supplement): 4547.

https://doi.org/10.1158/1538-7445.AM2012-4547

Published: 15 April 2012

View article titled, Abstract 4547: Clinical relevance of circulating tumor cells in esophageal cancer

Journal Articles

Abstract 3393: Identification of genes mediating early dissemination of tumor cells in breast cancer

Harriet Wikman, Volkmar Müller, Dirk Kemming, Sabine Riethdorf, Kathrin Eylmann, Jolanthe Kropidlowski, Roland Eils, Fritz Jänicke, Thomas Streichert, Benedikt Brors, Klaus Pantel

Cancer Res (2010) 70 (8_Supplement): 3393.

https://doi.org/10.1158/1538-7445.AM10-3393

Published: 15 April 2010

View article titled, Abstract 3393: Identification of genes mediating early dissemination of tumor cells in breast cancer

Journal Articles

Abstract 2165: Genomic profiling of colorectal cancers from patients diagnosed with circulating tumor cells

Simon Joosse, Catherine Alix-Panabieres, Eric Deneve, Christin Beneken, Marja Nieuwland, Ron Kerkhoven, J Ramos, Harriet Wikman, Lutz Riethdorf, Sabine Riethdorf, Klaus Pantel, Juliane Hannemann

Cancer Res (2010) 70 (8_Supplement): 2165.

https://doi.org/10.1158/1538-7445.AM10-2165

Published: 15 April 2010

View article titled, Abstract 2165: Genomic profiling of colorectal cancers from patients diagnosed with circulating tumor cells

Journal Articles

Abstract #4998: Quantitative assessment of circulating tumor cells in the mesenteric and peripheral blood of patients with colorectal cancer

Catherine Alix-Panabières, Sabine Riethdorf, Eric Denève, Grégoire Mercier, David Nocca, Jean-Pierre Vendrell, Klaus Pantel

Cancer Res (2009) 69 (9_Supplement): 4998.

Published: 01 May 2009

View article titled, Abstract #4998: Quantitative assessment of circulating tumor cells in the mesenteric and peripheral blood of patients with colorectal cancer

Journal Articles

Abstract #5413: Comparison of two CTC enrichment methods in primary and metastatic breast cancer patients

Katharina Effenberger, Sabine Riethdorf, Britta Kohlmorgen, Christine zu Eulenburg, Volkmar Muller, Julia Zeitz, Glenn Deng, Julian Burke, Klaus Pantel

Cancer Res (2009) 69 (9_Supplement): 5413.

Published: 01 May 2009

View article titled, Abstract #5413: Comparison of two CTC enrichment methods in primary and metastatic breast cancer patients

Journal Articles

Regulation of Estrogen-Dependent Transcription by the LIM Cofactors CLIM and RLIM in Breast Cancer

Steven A. Johnsen, Cenap Güngör, Tanja Prenzel, Sabine Riethdorf, Lutz Riethdorf, Naoko Taniguchi-Ishigaki, Thomas Rau, Baris Tursun, J. David Furlow, Guido Sauter, Martin Scheffner, Klaus Pantel, Frank Gannon, Ingolf Bach

Cancer Res (2009) 69 (1): 128–136.

https://doi.org/10.1158/0008-5472.CAN-08-1630

Published: 31 December 2008

View article titled, Regulation of Estrogen-Dependent Transcription by the LIM Cofactors CLIM and RLIM in Breast Cancer

Includes: Supplementary data

NARROW

Abstract 5827: Identification of potential novel drivers and biomarkers of CDK4/6 inhibitor resistance in metastatic breast cancer

Abstract 3370: Liquid biopsy approaches to determine tumor cell heterogeneity in advanced prostate cancer

Abstract PD18-07: Omission of chemotherapy in the treatment of HER2-positive and hormone-receptor positive metastatic breast cancer – interim results from the randomized phase 3 DETECT V trial

Abstract 3374: Large-scale single-cell whole transcriptomic analyses reveal distinct malignant phenotypes of CTCs from NSCLC patients

Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data

Abstract PD3-12: Efficacy of the tyrosine kinase inhibitor lapatinib in the treatment of patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells - results from the randomized phase III DETECT III trial

Abstract OT3-18-01: Detect III/IV study trial - The multicenter study program in patients with HER2-negative MBC and circulating tumor cells

Abstract OT2-01-03: DETECT V - Comparison of dual HER2-targeted therapy with trastuzumab and pertuzumab plus CDK4/6 inhibition in combination with either chemo- or endocrine therapy in patients with HER2-positive and hormone-receptor positive metastatic breast cancer

Abstract 2219: Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma of the bladder

Abstract CT066: Dendritic cell based cryoimmunotherapy associates with clinical variables and changes in T-cell receptor expression in a prospective phase I trial of metastatic castration resistant prostate cancer

Abstract 5581: Clinical validation of a highly sensitive assay to detect mutations in plasma from advanced lung adenocarcinoma patients

Abstract 5693: Low coverage genome-wide sequencing of cell-free DNA enables detection, therapeutic monitoring, and characterization of copy number alterations in patients with solid tumors

Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein Response

Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing

Abstract 4547: Clinical relevance of circulating tumor cells in esophageal cancer

Abstract 3393: Identification of genes mediating early dissemination of tumor cells in breast cancer

Abstract 2165: Genomic profiling of colorectal cancers from patients diagnosed with circulating tumor cells

Abstract #4998: Quantitative assessment of circulating tumor cells in the mesenteric and peripheral blood of patients with colorectal cancer

Abstract #5413: Comparison of two CTC enrichment methods in primary and metastatic breast cancer patients

Regulation of Estrogen-Dependent Transcription by the LIM Cofactors CLIM and RLIM in Breast Cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only